about
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges AheadLong-term results of the transmanubrial osteomuscular-sparing approach for pediatric tumors.[Soft tissue tumors in neonates].Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study.Autosomal-dominant primary immunodeficiencies.Desmoid fibromatosis in pediatric patients: management based on a retrospective analysis of 59 patients and a review of the literature.Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?Outcome of flat bone sarcomas (other than Ewing's) in children and adolescents: a study of 25 cases.Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines.Pulsed-dose rate brachytherapy for pediatric bladder prostate rhabdomyosarcoma: Compliance and early clinical results.Brachytherapy Combined With Surgery for Conservative Treatment of Children With Bladder Neck and/or Prostate Rhabdomyosarcoma.Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients.Impact of extensive surgery in multidisciplinary approach of pterygopalatine/infratemporal fossa soft tissue sarcoma.Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors.[Relapse after rhabdomyosarcoma in childhood and adolescence: Impact of an early detection on survival].Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity.Erratum to "desmoid fibromatosis in pediatric patients: management based on a retrospective analysis of 59 patients and a review of the literature".The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.Quality of life and functional outcome of male patients with bladder-prostate rhabdomyosarcoma treated with conservative surgery and brachytherapy during childhood.Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma.Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3).Patients in pediatric phase I and early phase II clinical oncology trials at Gustave Roussy: a 13-year center experience.Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection.Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience.[Desmoid tumors in children: current strategy].Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groupsIntegrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committeeIs surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experienceRobotic-assisted laparoscopic management of renal tumors in children: Preliminary resultsOutcome of localized liver-bile duct rhabdomyosarcoma according to local therapy: A report from the European Paediatric Soft-Tissue Sarcoma Study Group (EpSSG)-RMS 2005 studyOutcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB studyRituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children
P50
Q26797513-F8EF3D31-E191-4F35-AA70-525E5A02466AQ33276459-7DA80594-59C1-47D9-A1A9-50FB0B47D732Q33384245-E57605C8-C47F-48D9-9851-BDD06C97E739Q35485873-20CC2D0A-028B-49F2-83A0-823B95CCD50CQ35669884-00023C94-2B90-4E2D-AF84-2A3DA53588B3Q35987077-D31D7692-0C33-48FF-AF87-C2A780537C5CQ36167287-F64230A2-FADB-415B-97C5-E91AEA7338D4Q36289514-03A12366-1CBA-4EF8-9F1B-6F63B5E6A080Q36694532-07B65595-54F8-4955-9002-DA02B81B129FQ37379398-3AAF801A-E4E9-4FDD-81EF-1A2F460714E5Q38651079-3FEEB9DE-9EE0-4C12-B422-4336B63B304BQ38809378-C373E8E8-F7A0-45E8-A115-E89AA1C80928Q38886708-D52D840B-5527-4048-A0EC-E303A3067779Q39488682-6C4E9FE9-C9C2-47C6-869A-E19BDFDDB8F4Q39546314-6897780D-A396-4378-A262-B9BB79592528Q40131708-81B3CE08-18E5-4003-9426-9B21E95AA8D2Q40519163-DF3C24C9-6D8E-41E6-9BAC-4E57FC95C39AQ43217849-525CF78A-5D62-48FC-8307-A44A0666A6C8Q43292337-9E4B0D7A-6DE9-4357-B3FC-58B7E1F2F783Q47820169-FC4939AB-72C9-4ACE-9BA9-27D09CA17D6FQ48199650-F8EADDE7-9AC2-4DF7-81D1-43A09569F458Q48219972-6310A1B2-9FC5-4067-8FFB-D2EC8AEFB62DQ48576133-C360FE0B-0161-4990-BB53-1F026704C389Q49126642-97609162-9680-4E6E-AB22-03E2E40F31B8Q52357735-3757EB3C-AB38-4581-B9DA-533DB78E0825Q54310731-E5A2CD5B-D4ED-412C-9D9C-E5D935693D0FQ60636751-6D03E4FC-A634-4F88-A3A2-9C099520A1C7Q89842057-1C1F779E-A5AF-4AFD-A250-E2CD2849911CQ91372215-272D0A38-8751-4A9F-962A-CA2E48AF374AQ92340240-FAABDCEA-CF73-49E9-8333-8D046C3A2345Q92669334-A0934DAE-FFA4-4853-9A41-F82476972A37Q92807770-71009C00-4918-4078-866A-A045A1F7C484Q96122343-A6834874-8AFD-423E-A7FD-7EA1E05BEEE4
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Véronique Minard-Colin
@ast
Véronique Minard-Colin
@de
Véronique Minard-Colin
@en
Véronique Minard-Colin
@es
Véronique Minard-Colin
@fr
Véronique Minard-Colin
@nl
Véronique Minard-Colin
@sl
type
label
Véronique Minard-Colin
@ast
Véronique Minard-Colin
@de
Véronique Minard-Colin
@en
Véronique Minard-Colin
@es
Véronique Minard-Colin
@fr
Véronique Minard-Colin
@nl
Véronique Minard-Colin
@sl
altLabel
Véronique Colin-Minard
@en
prefLabel
Véronique Minard-Colin
@ast
Véronique Minard-Colin
@de
Véronique Minard-Colin
@en
Véronique Minard-Colin
@es
Véronique Minard-Colin
@fr
Véronique Minard-Colin
@nl
Véronique Minard-Colin
@sl
P214
P269
P106
P2038
Veronique_Minard-Colin
P21
P214
P269
P31
P496
0000-0002-0296-5207
P569
1972-01-01T00:00:00Z
P735
P7859
viaf-208052693